Olanzapine-induced oculogyric crisis in a patient with schizophrenia

Indian Journal of Medical Sciences

Volumn 62, Issue 6, 2008, Pages 238-239

  Chakraborty, Rudraprosad ^a   Chatterjee, Arunima ^a   Chaudhury, Suprakash ^a  

^a Ranchi Institute of Neuropsychiatry and Allied Sciences   (India)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; IMIPRAMINE; OLANZAPINE; PROMETHAZINE; RISPERIDONE; TRIHEXYPHENIDYL;

ADULT; ANXIETY; CASE REPORT; DEPRESSION; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; LETTER; MALE; MOTOR DYSFUNCTION; OCULOGYRIC CRISIS; PATHOPHYSIOLOGY; RESTLESSNESS; SCHIZOPHRENIA; SIDE EFFECT; TREMOR; UNSPECIFIED SIDE EFFECT;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DYSTONIA; HUMANS; MALE; OCULAR MOTILITY DISORDERS; SCHIZOPHRENIA;

EID: 46849083075     PISSN: 00195359     EISSN: 19983654     Source Type: Journal    
DOI: 10.4103/0019-5359.41611     Document Type: Letter

References (6)

1. Desarkar P, Das A, Sinha VK. Olanzapine induced oculogyric crisis. Aus NZJ Psychiatry 2006;40:374.
2. Mendhekar DN. Recurrent oculogyric crisis and retrocollis after re-exposure with a low dose of olanzapine. Indian J Pharmacol 2005;37:337.
3. Rosenhagen MC, Schmidt U, Winkelmann J, Ebinger M, Knetsch I, Weber F. Olanzapine-induced oculogyric crisis. J Clin Psychopharmacol 2006;26:431.
4. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
5. Shirzadi AA, Ghaemi SN. Side effects of atypical antipsychotics: Extrapyramidal symptoms and the metabolic syndromes. Harv Rev Psychiatry 2006;14:152-64.
6. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, et al. Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005;353:1209-23.